Hypercalcemia of malignancy in the palliative care patient: A treatment strategy
- 30 April 1995
- journal article
- case report
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 10 (3), 224-232
- https://doi.org/10.1016/0885-3924(94)00127-7
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Coincidental occurrence of primary hyperparathyroidism and cancer-associated hypercalcaemia in a middle-aged manClinical Endocrinology, 1993
- Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer centerCancer, 1993
- Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.Journal of Clinical Oncology, 1993
- Randomised, placebo-controlled multicentre trial of clodronate in multiple myelomaThe Lancet, 1992
- Management of Acute HypercalcemiaNew England Journal of Medicine, 1992
- Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemiaThe Lancet, 1992
- The Diagnosis and Treatment of Malignancy-Associated HypercalcemiaThe Endocrinologist, 1991
- Cancer-Associated Hypercalcemia: Morbidity and MortalityAnnals of Internal Medicine, 1990
- REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENTThe Lancet, 1987
- The clinical course of bone metastases from breast cancerBritish Journal of Cancer, 1987